Therapeutic Apheresis Market To 2032: Growth Analysis By Manufacturers, Regions, Types And Applications
The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2577.9 Mn in 2022 and is expected to reach US$ 5313 Mn by 2032. The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases. Therapeutic apheresis is a procedure of the removal of a blood component from a patient using the apheresis technology. Therapeutic apheresis is used for the purpose of removing defective cells. Therapeutic apheresis is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity. Basically there are three types of therapeutic apheresis procedure used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX) and cellular depletions. TPE is the removal of large volume of patient plasma and repla...